ResearcherUniversity of PittsburghActive in the last 2 years

Amir Ali Borhani

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8963-2984; OpenAlex author ID A5064936135. Sources: OpenAlex.

Their work

Papers: 3
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 11

Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 3

Editorial Comment: Screening Imaging for Early Detection of Pancreatic Ductal Adenocarcinoma in High-Risk Individuals: Is It Ready for Prime Time? Co-author DOI 10.2214/ajr.24.31532 ↗
Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.2214/ajr.19.21152 ↗
Prior History of Pancreatitis Accelerates the Development of Pancreatic Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000001160 ↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Anna Evans Phillips · 1 shared paper, 2018 · strength 0.11
- Paper Prior History of Pancreatitis Accelerates the Development of Pancreatic Adenocarcinoma. DOI 10.1097/mpa.0000000000001160 ↗
Dhiraj Yadav · 1 shared paper, 2018 · strength 0.11
- Paper Prior History of Pancreatitis Accelerates the Development of Pancreatic Adenocarcinoma. DOI 10.1097/mpa.0000000000001160 ↗
Randall E. Brand · 1 shared paper, 2018 · strength 0.11
- Paper Prior History of Pancreatitis Accelerates the Development of Pancreatic Adenocarcinoma. DOI 10.1097/mpa.0000000000001160 ↗
Melissa Ellen Hogg · 1 shared paper, 2020 · strength 0.10
- Paper Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Rese… DOI 10.2214/ajr.19.21152 ↗
Mitchell E. Tublin · 1 shared paper, 2020 · strength 0.10
- Paper Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Rese… DOI 10.2214/ajr.19.21152 ↗
Amer H. Zureikat · 1 shared paper, 2020 · strength 0.10
- Paper Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Rese… DOI 10.2214/ajr.19.21152 ↗
Herbert J. Zeh · 1 shared paper, 2020 · strength 0.10
- Paper Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Rese… DOI 10.2214/ajr.19.21152 ↗
Nathan Bahary · 1 shared paper, 2020 · strength 0.10
- Paper Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Rese… DOI 10.2214/ajr.19.21152 ↗
Brian A. Boone · 1 shared paper, 2020 · strength 0.10
- Paper Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Rese… DOI 10.2214/ajr.19.21152 ↗
Michael T. Lotze · 1 shared paper, 2020 · strength 0.10
- Paper Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Rese… DOI 10.2214/ajr.19.21152 ↗
Aatur Dilip Singhi · 1 shared paper, 2020 · strength 0.10
- Paper Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Rese… DOI 10.2214/ajr.19.21152 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.